ARCHIVES

Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

NCI blocked groups from phase III Iressa studies.

April 30, 2004

Mammography Screening Effective In Women Under 50: BCDDP

September 25, 1987

In Brief: Joseph Bertino Succeeds Bresnick As AACR President; Louise Strong Is President-Elect

March 31, 1995

NCI-Approved CTEP Trials For the Month of September

September 28, 2012

Obituary: Michale Keeling, of M.D. Anderson.

January 2, 2004

ASCO Calls For New Clinical Study Section, Endorses NCAB Action In Senate Testimony

July 23, 1993